Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study
Abstract Skin α-synuclein deposition is considered a potential biomarker for Parkinson’s disease (PD). Real-time quaking-induced conversion (RT-QuIC) is a novel, ultrasensitive, and efficient seeding assay that enables the detection of minute amounts of α-synuclein aggregates. We aimed to determine...
Guardado en:
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3a90bad7b05e46a19ec4caa217356998 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3a90bad7b05e46a19ec4caa217356998 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3a90bad7b05e46a19ec4caa2173569982021-11-21T12:26:41ZDiagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study10.1038/s41531-021-00242-22373-8057https://doaj.org/article/3a90bad7b05e46a19ec4caa2173569982021-11-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00242-2https://doaj.org/toc/2373-8057Abstract Skin α-synuclein deposition is considered a potential biomarker for Parkinson’s disease (PD). Real-time quaking-induced conversion (RT-QuIC) is a novel, ultrasensitive, and efficient seeding assay that enables the detection of minute amounts of α-synuclein aggregates. We aimed to determine the diagnostic accuracy, reliability, and reproducibility of α-synuclein RT-QuIC assay of skin biopsy for diagnosing PD and to explore its correlation with clinical markers of PD in a two-center inter-laboratory comparison study. Patients with clinically diagnosed PD (n = 34), as well as control subjects (n = 30), underwent skin punch biopsy at multiple sites (neck, lower back, thigh, and lower leg). The skin biopsy samples (198 in total) were divided in half to be analyzed by RT-QuIC assay in two independent laboratories. The α-synuclein RT-QuIC assay of multiple skin biopsies supported the clinical diagnosis of PD with a diagnostic accuracy of 88.9% and showed a high degree of inter-rater agreement between the two laboratories (92.2%). Higher α-synuclein seeding activity in RT-QuIC was shown in patients with longer disease duration and more advanced disease stage and correlated with the presence of REM sleep behavior disorder, cognitive impairment, and constipation. The α-synuclein RT-QuIC assay of minimally invasive skin punch biopsy is a reliable and reproducible biomarker for Parkinson’s disease. Moreover, α-synuclein RT-QuIC seeding activity in the skin may serve as a potential indicator of progression as it correlates with the disease stage and certain non-motor symptoms.Anastasia KuzkinaConnor BargarDaniela SchmittJonas RößleWen WangAnna-Lena SchubertCurtis TatsuokaSteven A. GunzlerWen-Quan ZouJens VolkmannClaudia SommerKathrin DopplerShu G. ChenNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Neurology. Diseases of the nervous system RC346-429 Anastasia Kuzkina Connor Bargar Daniela Schmitt Jonas Rößle Wen Wang Anna-Lena Schubert Curtis Tatsuoka Steven A. Gunzler Wen-Quan Zou Jens Volkmann Claudia Sommer Kathrin Doppler Shu G. Chen Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study |
description |
Abstract Skin α-synuclein deposition is considered a potential biomarker for Parkinson’s disease (PD). Real-time quaking-induced conversion (RT-QuIC) is a novel, ultrasensitive, and efficient seeding assay that enables the detection of minute amounts of α-synuclein aggregates. We aimed to determine the diagnostic accuracy, reliability, and reproducibility of α-synuclein RT-QuIC assay of skin biopsy for diagnosing PD and to explore its correlation with clinical markers of PD in a two-center inter-laboratory comparison study. Patients with clinically diagnosed PD (n = 34), as well as control subjects (n = 30), underwent skin punch biopsy at multiple sites (neck, lower back, thigh, and lower leg). The skin biopsy samples (198 in total) were divided in half to be analyzed by RT-QuIC assay in two independent laboratories. The α-synuclein RT-QuIC assay of multiple skin biopsies supported the clinical diagnosis of PD with a diagnostic accuracy of 88.9% and showed a high degree of inter-rater agreement between the two laboratories (92.2%). Higher α-synuclein seeding activity in RT-QuIC was shown in patients with longer disease duration and more advanced disease stage and correlated with the presence of REM sleep behavior disorder, cognitive impairment, and constipation. The α-synuclein RT-QuIC assay of minimally invasive skin punch biopsy is a reliable and reproducible biomarker for Parkinson’s disease. Moreover, α-synuclein RT-QuIC seeding activity in the skin may serve as a potential indicator of progression as it correlates with the disease stage and certain non-motor symptoms. |
format |
article |
author |
Anastasia Kuzkina Connor Bargar Daniela Schmitt Jonas Rößle Wen Wang Anna-Lena Schubert Curtis Tatsuoka Steven A. Gunzler Wen-Quan Zou Jens Volkmann Claudia Sommer Kathrin Doppler Shu G. Chen |
author_facet |
Anastasia Kuzkina Connor Bargar Daniela Schmitt Jonas Rößle Wen Wang Anna-Lena Schubert Curtis Tatsuoka Steven A. Gunzler Wen-Quan Zou Jens Volkmann Claudia Sommer Kathrin Doppler Shu G. Chen |
author_sort |
Anastasia Kuzkina |
title |
Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study |
title_short |
Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study |
title_full |
Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study |
title_fullStr |
Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study |
title_full_unstemmed |
Diagnostic value of skin RT-QuIC in Parkinson’s disease: a two-laboratory study |
title_sort |
diagnostic value of skin rt-quic in parkinson’s disease: a two-laboratory study |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/3a90bad7b05e46a19ec4caa217356998 |
work_keys_str_mv |
AT anastasiakuzkina diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT connorbargar diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT danielaschmitt diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT jonasroßle diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT wenwang diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT annalenaschubert diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT curtistatsuoka diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT stevenagunzler diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT wenquanzou diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT jensvolkmann diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT claudiasommer diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT kathrindoppler diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy AT shugchen diagnosticvalueofskinrtquicinparkinsonsdiseaseatwolaboratorystudy |
_version_ |
1718418999728930816 |